Max Healthcare Institute Ltd (MAXHEALTH) is currently trading at 1,040.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Max Healthcare Institute Ltd. (MHC) is one of India's leading private-sector healthcare providers, operating 20 facilities with a focus on tertiary and quaternary care. In Q2 FY26, MHC's gross revenue soared by 21% YoY, driven by an increase in Occupied Bed Days, while PAT rose by 59%, bolstered by favorable tax adjustments from recent mergers. MHC is implementing a significant capacity expansion strategy, adding new beds in urban centers and divesting non-core rural assets to concentrate on super-specialty services. International patient revenue contributes around 9% of hospital revenues, showing a 25% YoY increase, indicating strong international market engagement. The launch of advanced oncology services, including a new radiation oncology program in Mohali and enhancements in Mumbai, demonstrates MHC's commitment to cutting-edge healthcare solutions.

Over the past 52 weeks, Max Healthcare Institute Ltd has traded between a low of ₹933.80 and a high of ₹1,314.30. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Max Healthcare Institute Ltd has a market capitalization of approximately 1,01,191.92. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Max Healthcare Institute Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 69.41 and operates in the Healthcare sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Max Healthcare Institute Ltd (MAXHEALTH) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 1,01,191.92 Cr, Max Healthcare Institute Ltd is classified as a Mid Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Max Healthcare Institute Ltd operates in the Healthcare sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Max Healthcare Institute Ltd is 69.41. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Max Healthcare Institute Ltd pays dividends with a current dividend yield of 0.14%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Max Healthcare Institute Ltd include sector-specific challenges in the Healthcare industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.